Herpes Research Today is a free monthly online journal that collates and summarizes the latest research about Herpes, including details on herpes simplex virus (hsv), genital, oral, symptoms, treatment.

Volume 2 (2005), Issue 3 (March)

1. Clinicopathological characterization of monkey B virus (Cercopithecine herpesvirus 1) infection in mice.
   J Comp Pathol, 132(2): 202-17. [Abstract] [Full-text]
2. Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant.
   Pediatrics, 115(3): 804-9. [Abstract] [Full-text]
3. The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus.
   Virology, 334(1): 51-8. [Abstract] [Full-text]
4. A DNA recombination-based approach to eliminate papillomavirus infection.
   Gene Ther, 12(6): 534-40. [Abstract] [Full-text]
5. Development of a therapeutic vaccine for HSV-2.
   Vaccine, 23(17): 2395-8. [Abstract] [Full-text]
6. Decrease in inflammatory hyperalgesia by herpes vector-mediated knockdown of Nav1.7 sodium channels in primary afferents.
   Hum Gene Ther, 16(2): 271-7. [Abstract] [Full-text]
7. Homing in on the cellular immune response to HSV-2 in humans.
   Am J Reprod Immunol, 53(4): 172-81. [Abstract] [Full-text]
8. Plasmacytoid dendritic cell reconstitution following bone marrow transplantation: subnormal recovery and functional deficit of IFN-alpha/beta production in response to herpes simplex virus.
   J Interferon Cytokine Res, 25(3): 135-43. [Abstract] [Full-text]
9. Herpes simplex virus entry mediator associates in infected cells in a complex with viral proteins gD and at least gH.
   J Virol, 79(7): 4540-4. [Abstract] [Full-text]
10. Control of VP16 translation by the herpes simplex virus type 1 immediate-early protein ICP27.
    J Virol, 79(7): 4120-31. [Abstract] [Full-text]
11. Herpes simplex virus infection stabilizes cellular IEX-1 mRNA.
    J Virol, 79(7): 4090-8. [Abstract] [Full-text]
12. ICP27 recruits Aly/REF but not TAP/NXF1 to herpes simplex virus type 1 transcription sites although TAP/NXF1 is required for ICP27 export.
    J Virol, 79(7): 3949-61. [Abstract] [Full-text]
13. Induction of secretory aspartyl proteinase of Candida albicans by HIV-1 but not HSV-2 or some other microorganisms associated with vaginal environment.
    Mycopathologia, 159(2): 213-8. [Abstract] [Full-text]
14. Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.
    Cancer Gene Ther, 12(4): 359-68. [Abstract] [Full-text]
15. Widespread intratumoral virus distribution with fractionated injection enables local control of large human rhabdomyosarcoma xenografts by oncolytic herpes simplex viruses.
    Cancer Gene Ther, 12(4): 407-16. [Abstract] [Full-text]
16. Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule.
    Mol Ther, 11(4): 617-26. [Abstract] [Full-text]
17. Attenuation of pain-related behavior in a rat model of trigeminal neuropathic pain by viral-driven enkephalin overproduction in trigeminal ganglion neurons.
    Mol Ther, 11(4): 608-16. [Abstract] [Full-text]
18. Detection of HSV and EBV in esophageal carcinomas from a high-incidence area in Shantou China.
    Dis Esophagus, 18(1): 46-50. [Abstract] [Full-text]
19. Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998.
    Eur J Clin Microbiol Infect Dis, 24(2): 131-5. [Abstract] [Full-text]
20. Mathematical analysis demonstrates that interferons-beta and -gamma interact in a multiplicative manner to disrupt herpes simplex virus replication.
    J Theor Biol, 234(3): 439-54. [Abstract] [Full-text]
21. Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors.
    Gene Ther, 12(7): 588-96. [Abstract] [Full-text]
22. Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo.
    Gene Ther, 12(7): 559-69. [Abstract] [Full-text]
23. Cytokine profiles and inflammatory cells during HSV-1-induced acute retinal necrosis.
    Invest Ophthalmol Vis Sci, 46(4): 1356-63. [Abstract] [Full-text]
24. Pathogenic potentials of glycoprotein C-negative syncytial mutants from rabbit T cells infected persistently with herpes simplex virus type 1.
    J Med Virol, 76(1): 89-97. [Abstract] [Full-text]
25. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen.
    J Leukoc Biol, 77(4): 552-9. [Abstract] [Full-text]
26. ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection.
    J Virol, 79(8): 5078-89. [Abstract] [Full-text]
27. A branched, synthetic oligopeptide corresponding to a region of glycoprotein G of HSV-1 reacts sensitively and specifically with HSV-1 antibodies in an ELISA.
    J Virol Methods, 125(2): 137-43. [Abstract] [Full-text]
28. Oncolytic herpes simplex virus mutants are more efficacious than wild-type adenovirus Type 5 for the treatment of high-risk neuroblastomas in preclinical models.
    Pediatr Blood Cancer, 44(5): 469-78. [Abstract] [Full-text]
29. T-cell transformation and oncogenesis by gamma2-herpesviruses.
    Adv Cancer Res, 93: 91-128. [Abstract] [Full-text]
30. Simultaneous detection of herpes simplex virus types 1 and 2 by real-time PCR and Pyrosequencing.
    J Clin Virol, 33(1): 25-34. [Abstract] [Full-text]
31. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2.
    Sex Transm Infect, 81(2): 103-7. [Abstract] [Full-text]

© 2004-2008 Herpes Research Today. All Rights Reserved.